Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mf...

FDA Drug Recall #D-1489-2019 — Class I — June 28, 2019

Recall Summary

Recall Number D-1489-2019
Classification Class I — Serious risk
Date Initiated June 28, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Kabi USA, LLC
Location Melrose Park, IL
Product Type Drugs
Quantity 14,016 vials

Product Description

Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]

Reason for Recall

Presence of Particulate Matter; glass particulates

Distribution Pattern

Nationwide USA and Puerto Rico

Lot / Code Information

Lot 6120420 NDC 63323-117-61, Product Code 101761 and Lot 6120341 NDC 63323-117-69, Product Code NP101761

Other Recalls from Fresenius Kabi USA, LLC

Recall # Classification Product Date
D-0182-2026 Class I Famotidine Injection, USP, 20 mg per 2 mL (10 m... Nov 6, 2025
D-0127-2023 Class II Sensorcaine (Bupivacaine HCl and Epinephrine In... Nov 22, 2022
D-0128-2023 Class II Sensorcaine (Bupivacaine HCl and Epinephrine In... Nov 22, 2022
D-0129-2023 Class II Sensorcaine-MPF (Bupivacaine HCl and Epinephrin... Nov 22, 2022
D-0750-2022 Class I Sodium Acetate Injection, USP, 400 mEq / 100 mL... Mar 4, 2022

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.